Pfizer (PFE) to Discontinue Bococizumab Development Program; Sees EPS Impact
Go back to Pfizer (PFE) to Discontinue Bococizumab Development Program; Sees EPS Impact| PANDORA MEDIA, Inc. (NYSE: P) | Delayed: 83.74 -0.18 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $83.92 | 52 Week High | $16.23 | |||
| Open | $84.61 | 52 Week Low | $7.10 | |||
| Day High | $86.10 | P/E | N/A | |||
| Day Low | $83.25 | EPS | $-0.15 | |||
| Volume | 2,389,578 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.81 +0.40 (1.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.41 | 52 Week High | $37.39 | |||
| Open | $25.50 | 52 Week Low | $28.25 | |||
| Day High | $25.81 | P/E | 15.64 | |||
| Day Low | $25.30 | EPS | $1.65 | |||
| Volume | 47,106,430 | |||||
